FibroScan®
Unlocking Better Patient Outcomes: Why Liver Health Is the Key to Metabolic Wellness
Context
|
Liver health isn’t just about liver disease – it’s a crucial indicator and driver of metabolic health. Despite its critical role, liver health often remains overlooked in routine cardiometabolic care. In this white paper, Dr. Martin Grajower, a leading endocrinologist, explains how addressing liver health proactively can significantly improve patient outcomes across metabolic diseases, including diabetes, obesity, and cardiovascular conditions. |
 |
Key learnings
The Hidden Epidemic
Understand why metabolic dysfunction-associated steatotic liver disease (MASLD) is widespread yet frequently undiagnosed among patients with obesity and type 2 diabetes.
Beyond Traditional Tests
Discover why standard liver tests often fail to detect early liver disease effectively and how this gap can lead to severe complications.
The Power of Early Detection
Learn how integrating FibroScan® can identify liver disease early, guide personalized patient care, and improve long-term health outcomes.
Optimizing Care with GLP-1 Therapies
Explore how FibroScan® can support clinicians in obtaining insurance approval for GLP-1 therapies by providing quantifiable evidence of liver health.
Reimbursement Strategies
Get actionable guidance on effectively coding and billing FibroScan® for reimbursement from insurance providers.
Real-World Clinical Integration
Gain practical insights from real-world examples on effectively integrating FibroScan® into everyday clinical workflows to optimize patient care and engagement.
Download the white paper to discover how prioritizing liver health can transform your approach to metabolic care.